LANXESS and Advent International complete foundation of industry leading Engineering Materials joint venture

Cologne

Specialty chemicals company LANXESS and private equity investor Advent International (“Advent”) have completed the formation of their engineering materials joint venture effective April 1, 2023. The new joint venture is the result of the combination of DSM’s Engineering Materials business and LANXESS’s former High Performance Materials business.

LANXESS holds about 40 percent of the joint venture, Advent about 60 percent. LANXESS also received a cash payment of around EUR 1.3 billion on March 31. LANXESS is using this mainly to reduce its debt and thus to strengthen its balance sheet.

As financial support for the joint venture, LANXESS will be providing a loan of EUR 200 million.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

MORE ABOUT THIS TOPIC

PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS increases sales and earnings in the third quarter of 2026

November 05, 2026
PRESS RELEASE
Woman put the cream on skin.

LANXESS Introduces Cosmelin Biodegradable Ester Portfolio for Cosmetics and Personal Care

October 26, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS will present its new disinfectant, Rely+On Medero, for the first time at Medica 2026

October 22, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS launches highly effective disinfectant for the medical sector

October 20, 2026
PRESS RELEASE
PIR insulation panel, aluminium-laminated

LANXESS sharpens flame-retardant portfolio for rigid PU and PIR insulation

September 22, 2026